Related by context. All words. (Click for frequent words.) 78 Camptosar ® 78 Capecitabine 78 Gemcitabine 78 Docetaxel 77 Oxaliplatin 77 Pemetrexed 77 thalidomide Thalomid 77 Bevacizumab 76 Erlotinib 76 pegylated liposomal doxorubicin 76 Fluorouracil 76 Neoadjuvant 76 Peginterferon 76 sorafenib Nexavar 76 Etoposide 76 erlotinib Tarceva ® 76 5 Fluorouracil 75 dasatinib Sprycel ® 75 Dasatinib 75 Taxotere docetaxel 75 Trastuzumab 75 Fludara ® 75 bevacizumab Avastin ® 75 gemcitabine Gemzar 75 Amrubicin 75 bevacizumab Avastin 75 alkylating agent 75 Epirubicin 75 Carboplatin 75 Cyclophosphamide 75 GW# [003] 75 Bosutinib 75 Gefitinib 75 Vandetanib 75 Tacrolimus 75 trabectedin 74 cetuximab Erbitux R 74 paclitaxel Taxol 74 Neulasta ® 74 Fulvestrant 74 Mitoxantrone 74 cyclophosphamide methotrexate 74 alpha 2a 74 Fludarabine 74 Paraplatin ® 74 Pertuzumab 74 Melphalan 74 Taxotere ® 74 Dapagliflozin 74 Meets Primary Endpoint 74 Aflibercept 74 DOXIL 74 docetaxel Taxotere 74 FOLFIRI 74 Adjuvant Treatment 74 Bortezomib 74 Peginterferon alfa 2b 74 Lubiprostone 74 Fluconazole 74 PEGylated anti 74 alfa 2a 74 Zorbtive TM 73 Fludara 73 Ganciclovir 73 Aliskiren 73 adalimumab Humira 73 docetaxel Taxotere ® 73 imatinib Gleevec ® 73 Medoxomil 73 Temsirolimus 73 Nilotinib 73 Ixempra 73 histone deacetylase HDAC inhibitor 73 Pegylated Interferon 73 Peg IFN 73 receptor tyrosine kinase inhibitor 73 Hycamtin ® 73 Everolimus 73 Velcade bortezomib 73 carboplatin paclitaxel 73 5FU 73 5 FU leucovorin 73 Noxafil 73 liposomal formulation 73 Topotecan 73 meropenem 73 PEGylated Fab fragment 73 Fluticasone 73 cisplatin gemcitabine 73 Anastrozole 73 Leucovorin 73 Degarelix 73 Moxifloxacin 73 Dacogen decitabine 73 Nexavar ® 73 Levoleucovorin 73 gefitinib Iressa 73 Hycamtin 73 Bendamustine 72 Hsp# Inhibitor 72 Ranolazine 72 Patients Treated With 72 lapatinib Tykerb 72 DFMO 72 Cisplatin 72 Vidaza azacitidine 72 Ozarelix 72 FOLFOX6 72 Gemzar ® 72 SPRYCEL ® 72 mertansine 72 Metastatic Colorectal Cancer 72 Octreotide 72 dasatinib Sprycel 72 FASLODEX 72 Hormone Refractory Prostate Cancer 72 Filgrastim 72 targeted radiotherapeutic 72 Bicalutamide 72 YONDELIS 72 Maribavir 72 TNF Tumor Necrosis Factor 72 biologic DMARD 72 Sorafenib 72 Doxil ® 72 Navelbine ® 72 Lenalidomide 72 estramustine 72 Torisel 72 metastatic malignant 72 capecitabine Xeloda 72 Granulocyte Colony Stimulating Factor 72 vorinostat 72 Xeloda ® 72 Antitumor Activity 72 Prolongs Survival 72 Interferon alfa 72 cetuximab Erbitux ® 72 sorafenib tablets 72 goserelin 72 mycophenolate mofetil 72 Paclitaxel 72 ethambutol 72 Pharmacokinetics PK 72 herpetic keratitis 72 Clevudine 72 Gliadel Wafer 72 Tamibarotene 72 ritonavir boosted 72 Azacitidine 72 beta 1a 72 methylnaltrexone bromide 72 Pfizer Sutent 72 relapsed ovarian cancer 72 Rituximab 72 Platinol ® 72 Nexavar sorafenib 72 Exemestane 71 mesylate 71 pegfilgrastim 71 adriamycin 71 standard chemotherapy regimen 71 amifostine 71 Gleevec resistant 71 SIR Spheres 71 Bezielle 71 Mitomycin C 71 micafungin 71 oral prodrug 71 pegylated interferon alpha 71 Monotherapy 71 dexamethasone Decadron 71 nucleoside analog 71 Phase III Clinical Trial 71 Aptivus ® 71 Neupogen ® 71 bendamustine 71 ceftazidime 71 refractory chronic lymphocytic 71 docetaxel chemotherapy 71 paclitaxel Taxol R 71 Azathioprine 71 Alkeran 71 Fondaparinux 71 trastuzumab Herceptin R 71 Nitazoxanide 71 Decitabine 71 Xelox 71 metastatic renal cell carcinoma 71 Interferon Alpha 71 MGd 71 ORENCIA ® 71 luteinizing hormone releasing 71 Darunavir 71 gastrointestinal stromal tumors GIST 71 bevacizumab Avastin R 71 pan HDAC inhibitor 71 5-FU/LV 71 biologic therapy 71 Xeloda capecitabine 71 Ziprasidone 71 Orally administered 71 cinacalcet 71 sunitinib Sutent ® 71 Camptosar ® irinotecan 71 HuMax EGFr 71 Pazopanib 71 Cytarabine 71 Doxorubicin 71 dacarbazine 71 TEMODAL 71 Vaprisol 71 CHOP chemotherapy 71 Copegus ribavirin 71 vinorelbine tartrate 71 Mg Usa 71 peginterferon alpha 2a 71 BCG refractory carcinoma 71 metastatic colorectal 71 Posaconazole 71 boosted protease inhibitor 71 Bevacizumab Avastin 71 Complicated Skin 71 AEG# 71 immunoconjugate 71 Tezampanel 71 Herceptin trastuzumab 71 vinca alkaloid 71 Vicinium TM 71 multi kinase inhibitor 71 ZOLINZA 71 PKC# 71 Liposomal 71 trastuzumab Herceptin 71 aripiprazole Abilify 71 mapatumumab 71 etanercept Enbrel 71 proteasome inhibitor 71 ganciclovir 70 gemcitabine chemotherapy 70 Recombinant Human 70 leukotriene receptor antagonist 70 FOLFOX4 70 angiotensin receptor blocker ARB 70 Cetuximab Erbitux 70 IV Busulfex 70 Pegasys ® 70 gemcitabine cisplatin 70 AVASTIN 70 chemotherapy cisplatin 70 Mycophenolate Mofetil 70 Traficet EN 70 pertuzumab 70 Tarceva TM 70 Voreloxin 70 bortezomib Velcade 70 Eltrombopag 70 plasma kallikrein inhibitor 70 fluoropyrimidine 70 FUSILEV enhances 70 mRCC 70 CIMZIA TM 70 Enzyme Replacement Therapy 70 biliary tract cancer 70 polymerase inhibitor 70 xanthine oxidase inhibitor 70 Drug Candidate 70 abacavir Ziagen 70 diclofenac sodium 70 infusional 5-FU/LV 70 Pivotal Phase III 70 INTEGRILIN R 70 ZACTIMA 70 anti angiogenic agent 70 Proxinium TM 70 Levofloxacin 70 TAXOTERE R 70 carmustine 70 DEFLUX 70 pegylated interferon alfa 2a 70 Amplimexon 70 Cloretazine 70 Aplidin 70 Mepact 70 5 fluorouracil leucovorin 70 CAELYX 70 sunitinib malate 70 Anthracycline 70 Zarnestra 70 corticosteroid dexamethasone 70 mTOR inhibitor 70 VALSTAR 70 Tocilizumab 70 relapsed MM 70 raloxifene Evista 70 XELOX 70 decitabine 70 histone deacetylase inhibitor 70 Taxol ® 70 Zolinza 70 LHRH antagonist 70 Ambrisentan 70 Palonosetron 70 Phase IIb Trial 70 HSP# inhibitor 70 Ciclesonide 70 Caelyx 70 Pegintron 70 Methylnaltrexone 70 dihydrochloride 70 ribavirin RBV 70 idarubicin 70 NXL# 70 Neulasta R 70 Folfox 70 Mg Uk 70 platelet inhibitor 70 comparator arm 70 relapsing multiple sclerosis 70 Initiate Clinical Trial 70 regorafenib 70 topotecan 70 Bivalirudin 70 ixabepilone 70 Tindamax 70 docetaxel Taxotere R 70 DORIBAX 70 fluorouracil 70 5 fluorouracil 70 BARACLUDE ® 70 Allovectin 7 70 MabCampath 70 Taxol paclitaxel 70 Gleevec imatinib mesylate 70 TORISEL 70 Boceprevir 70 HuMax CD4 70 MAGE A3 ASCI 70 Kepivance 70 nab paclitaxel 70 intravesical instillation 70 evaluating tivozanib 70 alefacept 70 cidofovir 70 letrozole Femara 70 vinca alkaloids 70 JAK Inhibitor 70 Trabectedin 70 Indomethacin 70 AZT zidovudine Retrovir 70 antibody MAb 70 piperacillin tazobactam 70 Tipranavir 70 Losartan 70 Dabigatran 70 situ CIS 70 Tasigna nilotinib 70 melphalan prednisone 70 Adjuvant Therapy 70 Copegus ® 70 Piperacillin 70 somatostatin analogue 70 Investigational Treatment 70 tenofovir Viread 70 paclitaxel carboplatin 70 octreotide acetate 70 zidovudine AZT 70 echinocandin 70 IL# PE#QQR 70 lexidronam injection 70 Omacetaxine 70 Erbitux cetuximab 70 IAP inhibitors 70 Improved Survival 70 Epratuzumab 70 Cancidas 70 Pafuramidine 70 Torisel temsirolimus 70 AVONEX ® 70 TELINTRA 70 SCCHN 69 Relapsed Refractory 69 ara C 69 imatinib Gleevec 69 TREANDA 69 TLR9 agonist 69 superficial bladder cancer 69 invasive candidiasis 69 abacavir lamivudine 69 Alemtuzumab 69 pegylated interferon alfa 69 EGFR TKI 69 intravenously administered 69 MKC# MKC# PP 69 azacytidine 69 cell lymphoma CTCL 69 topical gel formulation 69 amrubicin 69 gastrointestinal stromal tumors 69 leukemia AML 69 Temozolomide 69 IMiDs ® compound 69 CIMZIA ™ 69 immunomodulatory therapy 69 Microspheres 69 Natalizumab 69 Xanafide 69 leucovorin 69 Myocet 69 Cytoxan 69 Annamycin 69 myelodysplastic myeloproliferative diseases 69 Panzem R NCD 69 Roche Xeloda 69 tamoxifen citrate 69 Naive Patients 69 administered subcutaneously 69 antiplatelet agent 69 IRESSA 69 DOXIL ® 69 Mesalamine 69 Epidermal Growth Factor Receptor 69 Rituxan rituximab 69 Tamsulosin 69 microtubule inhibitor 69 RhuDex ® 69 Severe Sepsis 69 HuLuc# 69 daunorubicin 69 denileukin diftitox 69 Thrombin 69 Talabostat 69 Ranibizumab 69 TLK# 69 XYOTAX TM 69 HERCEPTIN 69 paclitaxel Taxol ® 69 novel emulsion formulation 69 IMA# 69 erlotinib Tarceva 69 Parnate 69 Elitek 69 Halaven 69 R bendamustine hydrochloride 69 PEG interferon 69 liposomal doxorubicin 69 ergot derivatives 69 Patients Treated 69 Well Tolerated 69 ibandronate 69 VAPRISOL 69 Combination Therapy 69 interferon ribavirin 69 Campath alemtuzumab 69 Luteinizing Hormone Releasing Hormone 69 bleomycin 69 Radioimmunotherapy 69 NOXAFIL 69 reslizumab 69 bicalutamide 69 sodium glucose cotransporter 69 cefuroxime 69 chimeric monoclonal antibody 69 amphotericin B 69 Interferon beta 1a 69 FIRMAGON 69 Chemoradiation 69 acetonide FA 69 Interferon beta 69 Lapatinib 69 generation purine nucleoside 69 interferon gamma 1b 69 Cilostazol 69 Sitagliptin 69 angiogenesis inhibitor 69 nucleotide analogue 69 Vfend 69 Inhalation Aerosol 69 CYT# potent vascular disrupting 69 Dose Ranging Study 69 clodronate 69 radiation sensitizer 69 Pirfenidone 69 Diabetic Neuropathy 69 #mg/#mg 69 Personalized Immunotherapy 69 Betaferon R 69 Nebulized 69 Pivotal Study 69 RAPAFLO 69 Telbivudine 69 Single Dose 69 ONCASPAR 69 doxorubicin cyclophosphamide 69 Phase 2b Clinical Trial 69 hormone LHRH antagonist 69 acyclovir Lauriad R 69 oblimersen 69 glatiramer acetate 69 posaconazole 69 irbesartan 69 Seliciclib 69 Ecallantide 69 Cellegesic 69 HER2 positive metastatic breast 69 efalizumab 69 Kinase Inhibitor 69 Combination therapy 69 Zoledronic acid 69 somatostatin analog 69 Interferon alpha 69 intranasal formulation 69 Quinamed 69 PSMA ADC 69 Radiofrequency Ablation RFA 69 sunitinib Sutent 69 etoposide 69 Denufosol 69 fallopian tube carcinoma 69 Metastatic Melanoma 69 adenosine injection 69 Proquin XR 69 #mg Tablets [002] 69 mycophenolate mofetil MMF 69 Ofatumumab 69 FOR FURTHER INFORMATION ABOUT 69 Blinatumomab 69 basiliximab 69 BCG refractory 69 humanized monoclonal 69 Factor VIIa 69 pharmacologically active isomer 69 Clolar ® 69 Zemplar 69 Vinorelbine 69 Itraconazole 69 Budesonide 69 Lamivudine 69 Cutaneous T 69 Safinamide 69 fallopian tube cancers 69 oral rivaroxaban 69 Adefovir 69 Sustiva efavirenz 69 ThermoDox R 69 R Saizen R 69 YONDELIS R 69 Serostim ® 69 R lenalidomide 69 protease inhibitor PI 69 chemotherapy FOLFOX 69 chemoradiation therapy 69 2 methoxyestradiol 69 tazobactam 69 PNP inhibitor 69 nucleoside reverse transcriptase inhibitor 69 Soft Tissue Sarcoma 69 LHRH 69 proteasome inhibitors 69 fumarate 69 Onconase 69 trimethoprim sulfamethoxazole 69 irinotecan chemotherapy 69 Leukine ® 69 Chronic Hepatitis C 69 Low Dose 69 Eraxis 69 Dabigatran etexilate 69 Angiotensin Converting Enzyme 69 tipranavir 69 TO AVOID PREGNANCY WHILE 69 taxane 69 Receives Orphan Drug Designation 69 CoFactor 69 prucalopride 69 tigecycline 69 Advagraf 69 Advanced Melanoma 68 lenalidomide Revlimid R 68 interferon alfa 68 Androgen Deprivation Therapy 68 oxaliplatin Eloxatin 68 ARIXTRA R 68 infliximab Remicade 68 Imatinib 68 panitumumab Vectibix 68 Lamotrigine 68 SPIRIVA ® 68 Previously Treated 68 Fingolimod 68 Infliximab 68 alfa 2b 68 Bisphosphonate 68 PEGINTRON TM 68 ACE Inhibitors 68 Temodar ® 68 thymalfasin 68 epirubicin 68 volociximab 68 pioglitazone HCl 68 Ribavirin 68 PEG IFN 68 pyrazinamide 68 Raptiva ® 68 Tyrosine Kinase Inhibitor 68 vandetanib 68 Is Well Tolerated 68 brand ciclesonide HFA 68 oropharyngeal candidiasis OPC 68 trastuzumab Herceptin ® 68 TYGACIL 68 assessing T DM1 68 azacitidine 68 Daclizumab 68 Cyclosporine 68 DEB# 68 malignant ascites 68 Soriatane 68 tyrosine kinase inhibitor 68 Phase 2b Study 68 Abatacept 68 orally dosed 68 tinidazole 68 Platinol ® cisplatin 68 INVANZ 68 Clindamycin 68 ELOXATIN 68 Ixabepilone 68 vapreotide acetate 68 Advanced Renal Cell 68 temsirolimus 68 HDAC Inhibitor 68 AGGRASTAT R Injection tirofiban 68 voriconazole 68 Calcitonin 68 Elotuzumab 68 relapsed multiple myeloma 68 HCl Injection 68 Silodosin 68 Ticagrelor 68 alpha interferons 68 AAG geldanamycin analog 68 Phase III Trial 68 ADP receptor antagonist 68 Resten NG 68 anticancer compound 68 metformin HCl 68 Apaziquone 68 Initiate Phase 68 FUSILEV ® 68 Alinia 68 pancreatic enzyme replacement 68 Vincristine 68 nilotinib Tasigna 68 Myelodysplastic Syndrome MDS 68 trans retinoic acid ATRA 68 Elagolix 68 ULORIC 68 AMEVIVE 68 trans retinoic acid 68 GRASPA ® 68 lanreotide 68 metaglidasen 68 glatiramer 68 Carvedilol 68 Mycamine 68 Investigational Agent 68 Troxatyl 68 Toremifene 68 Wafer polifeprosan 68 Entecavir 68 abatacept Orencia 68 PDE4 inhibitor 68 metastatic hormone refractory 68 Certolizumab pegol 68 BCR ABL inhibitor 68 targeted antifolate 68 amikacin 68 Mimpara 68 AMMONUL R sodium phenylacetate 68 multikinase inhibitor 68 vidofludimus 68 Tumor Necrosis Factor 68 demonstrated antitumor activity 68 efaproxiral 68 Renal Cell Carcinoma 68 Interferon Beta 68 mesalazine 68 chemotherapeutic drug 68 demethylating agent 68 metastatic castration resistant 68 Tesetaxel 68 Sapacitabine 68 Panzem R 68 dalteparin 68 depsipeptide 68 selective modulator 68 cetuximab Erbitux 68 Pivotal Phase 68 Intravesical 68 Pegylated Liposomal Doxorubicin 68 lumiliximab 68 APTIVUS 68 Randomized Phase 68 Hydrochlorothiazide 68 estrogen receptor antagonist 68 levoleucovorin 68 basal cell carcinoma BCC 68 chlorambucil 68 Elvitegravir 68 Pegloticase 68 Cetrorelix 68 Study Evaluating 68 ChronVac C R 68 R sorafenib tablets 68 systemic antifungal 68 Valopicitabine 68 idraparinux 68 Pioglitazone 68 Albuferon TM 68 Generic Version 68 generation Hsp# inhibitor 68 HuMax 68 salmeterol fluticasone 68 miconazole Lauriad ® 68 efavirenz EFV 68 rituximab Rituxan 68 INTELENCE 68 metastatic neuroendocrine tumors 68 albumin bound paclitaxel 68 AKT inhibitor 68 Palifosfamide 68 Castration Resistant Prostate Cancer 68 sulindac 68 HyACT 68 liposomal amphotericin B 68 non nucleoside inhibitor 68 IgG1 monoclonal antibody 68 Arranon 68 chemotherapeutic regimen 68 interleukin IL -# 68 Laquinimod 68 Anti TNF 68 DU #b 68 Tanespimycin 68 candesartan cilexetil 68 topical ocular 68 telaprevir dosed 68 antiandrogen 68 CCX# B 68 Kit CD# positive 68 Ibritumomab Tiuxetan 68 Xyfid TM 68 Montelukast 68 injected subcutaneously 68 REYATAZ R 68 OMP #M# 68 Parathyroid Hormone 68 Arimidex anastrozole 68 recurrent glioblastoma multiforme 68 oral diclofenac 68 Golimumab 68 Raltegravir 68 Avastin bevacizumab 68 octreotide 68 Investigational Compound 68 Didanosine 68 Clofarabine 68 BUPHENYL R sodium phenylbutyrate 68 Gonal f ® 68 CANCIDAS 68 phase IIb clinical 68 FDA APPROVES 68 cilengitide 68 virus HCV protease inhibitor 68 interferon alfa 2b 68 Initiates Enrollment 68 lamivudine 3TC 68 Clinical Trial Results 68 #I TM# 68 Omalizumab 68 Perifosine 68 Protease Inhibitor 68 Sudhir Agrawal D.Phil 68 esomeprazole Nexium 68 FOLFIRI alone 68 peripherally acting 68 Tarceva erlotinib 68 Helicobacter pylori eradication 68 intravesical infusion therapy 68 Haemophilus b Conjugate 68 lopinavir r 68 sapropterin dihydrochloride 68 icatibant 68 zoledronic acid Zometa 68 trabedersen 68 Previously Untreated 68 Improves Survival 68 Intravitreal 68 Peginterferon Alfa 2a 68 Expanded Indication 68 aspirin clopidogrel 68 gemcitabine carboplatin 68 pegylated interferons 68 Pharmacokinetic Study 68 Ceflatonin 68 mitomycin 68 recurrent metastatic 68 Dalbavancin 68 Genentech Rituxan 68 Mylan Receives Approval 68 zoledronate 68 EOquin TM 68 G#DT 68 temsirolimus Torisel 68 Abacavir 68 Sevelamer 68 Tesamorelin 68 Fenofibrate 68 ELACYT 68 Mipomersen 68 exemestane Aromasin 68 Soriatane R 68 5 HT3 antagonist 68 Bosentan 68 forodesine 68 Darusentan 68 Febuxostat 68 Glatiramer Acetate 68 mitoxantrone plus 68 advanced hepatocellular carcinoma 68 Loceryl ® 68 Eculizumab 68 daptomycin 68 HGS# 67 superficial basal cell carcinoma 67 Oral Fingolimod 67 Newly Diagnosed Multiple Myeloma 67 TYKERB 67 Azedra 67 chemotherapy docetaxel 67 Vancomycin 67 COMBIVIR 67 fluorouracil leucovorin 67 direct thrombin inhibitors 67 #/#mg 67 NDA Submission 67 FOLFOX chemotherapy 67 topical ophthalmic 67 KRN# 67 Afatinib 67 fluticasone furoate 67 Epivir 67 JAK inhibitor 67 antibody MT# 67 Femara letrozole 67 Glufosfamide 67 Anti VEGF 67 BENICAR HCT 67 humanised monoclonal antibody 67 Civacir 67 Oral Solution 67 1mg 2mg 67 sargramostim 67 lenalidomide dexamethasone 67 Inhalation Solution 67 thrombolytic agent 67 Novel Oral 67 terlipressin 67 pitavastatin 67 anti androgen 67 Oracea ® 67 hypereosinophilic syndrome 67 Rivaroxaban 67 Protease Inhibitors 67 Ovidrel 67 Dual Opioid 67 ACTEMRA TM 67 Taxotere R 67 imipenem 67 Pegasys peginterferon alfa 2a 67 Valacyclovir 67 Alocrest 67 Myelofibrosis 67 Platinol 67 benign prostatic hypertrophy BPH 67 erlotinib Tarceva R 67 CD# monoclonal antibody 67 investigational humanized monoclonal antibody 67 recurrent GBM 67 ribavirin USP 67 cisplatin chemotherapy 67 metastatic GIST 67 Doxil 67 selective phosphodiesterase 67 ibritumomab tiuxetan 67 ABVD 67 AEGR 67 Sprycel dasatinib 67 taxotere 67 Cloretazine ® 67 metastatic gastric 67 IXEMPRA 67 PARP inhibitor 67 sublingual tablets 67 fludarabine phosphate 67 plus DOXIL 67 EFAPROXYN 67 Teysuno 67 Combination REOLYSIN R 67 Bazedoxifene 67 Follicular Lymphoma 67 injection USP 67 IAP inhibitor 67 taxane chemotherapy 67 HER2 Positive Breast Cancer 67 imiquimod cream 67 ® lenalidomide 67 Completes Patient Enrollment 67 BEACOPP 67 miconazole Lauriad R 67 chronic eosinophilic leukemia 67 Romiplostim 67 hormone refractory metastatic prostate 67 Demonstrates Potent 67 vinorelbine 67 Etravirine 67 Jevtana 67 LY# [003] 67 advanced metastatic renal 67 Sandostatin R 67 anthracycline taxane 67 pharmacokinetic interactions 67 oral ridaforolimus 67 Treanda 67 Riluzole 67 octreotide LAR 67 ciprofloxacin hydrochloride 67 Autologous Stem Cell Transplantation 67 Gemzar gemcitabine 67 ALN HPN 67 Peginterferon alfa 2a 67 Rifampin 67 Archexin 67 Iluvien ® 67 orally administered inhibitor 67 interferon beta 1b 67 Gleevec imatinib 67 Danazol 67 FOLFOX 67 nucleoside analogs 67 Taxotere chemotherapy 67 recurrent NSCLC 67 cediranib 67 Liprotamase 67 peginterferon alfa 2a Pegasys 67 subcutaneously administered 67 Cetuximab 67 monoclonal anti 67 Cremophor 67 Kamada AAT 67 cyclophosphamide chemotherapy 67 Revlimid lenalidomide 67 IMiDs ® 67 3TC lamivudine Epivir 67 Survival Benefit 67 ritonavir boosted atazanavir 67 cutaneous T 67 Romidepsin 67 Sporanox 67 UPLYSO 67 GTC recombinant human 67 DepoDur 67 Bayer Onyx 67 arsenic trioxide injection 67 antimetabolite 67 infusional 67 proton pump inhibitor PPI 67 Imatinib mesylate 67 Tiotropium 67 Saizen R 67 unresectable liver cancer 67 dasatinib 67 Idiopathic Pulmonary Fibrosis 67 PGL# 67 paclitaxel poliglumex 67 INTEGRILIN ® 67 CD3 monoclonal antibody 67 Hepatocellular Carcinoma 67 tumors GIST 67 phase IIb trial 67 trastuzumab DM1 67 tenofovir emtricitabine 67 potentially hepatotoxic 67 Retinoic Acid 67 DOXIL R 67 Panitumumab 67 paclitaxel cisplatin 67 Dacogen injection